No Data
Private Companies Are Shandong Keyuan Pharmaceutical Co., Ltd.'s (SZSE:301281) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥618m Last Week
Kangyuan Pharmaceutical (301281.SZ): Currently not involved in medical consultation business.
Gelonghui November 5th, Ke Yuan Pharmaceuticals (301281.SZ) stated on the investor interaction platform that the company is mainly engaged in the research and development, production, and sales of chemical raw materials and their formulation products, and currently does not involve medical consulting businesses.
Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture
Optimistic Investors Push Shandong Keyuan Pharmaceutical Co., Ltd. (SZSE:301281) Shares Up 151% But Growth Is Lacking
Keyuan Pharmaceutical: Report for the third quarter of 2024
Ke Yuan Pharmaceuticals (301281.SZ) released its performance for the first three quarters, with a net income of 39.6831 million yuan, a year-on-year decrease of 40.38%.
Koyuan Pharmaceuticals (301281.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching 3....